Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma.
Reynolds
C P
CP
Division of Hematology-Oncology, Children's Hospital Los Angeles, University of Southern California, Keck School of Medicine, USA.
Seeger
R C
RC
D019046:Bone Marrow Neoplasms / Q000175:diagnosis*; D006801:Humans; D018365:Neoplasm, Residual; D009447:Neuroblastoma / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis